Pentadecanoylcarnitine (PDC) Cannabinoid Research

Pentadecanoylcarnitine (PDC) Research Dashboard


Primary Studies


Related Studies


Total Studies

Clinical Studies


Clinical Meta-analyses


Double-blind Clinical Trials


Clinical Trials

Pre-Clinical Studies




Animal Studies


Laboratory Studies

What am I missing as a non-subscriber?

To see a full dashboard with study details and filtering, go to our DEMO page.

As a subscriber, you will be able to access dashboard insights including chemotype overviews and dosing summaries for medical conditions and organ system and receptor breakdowns for cannabinoid and terpene searches. Study lists present important guidance including dosing and chemotype information with the ability to drill down to the published material. And all outputs are fully filterable, to help find just the information you need. Stay up-to-date with the science of cannabis and the endocannabinoid system with CannaKeys.

CannaKeys has 10 studies associated with Pentadecanoylcarnitine (PDC).

Here is a small sampling of Pentadecanoylcarnitine (PDC) studies by title:

Components of the Pentadecanoylcarnitine (PDC) Research Dashboard

  • Top medical conditions associated with Pentadecanoylcarnitine (PDC)
  • Proven effects in clinical trials for Pentadecanoylcarnitine (PDC)
  • Receptors associated with Pentadecanoylcarnitine (PDC)
  • Individual study details for Pentadecanoylcarnitine (PDC)

Ready to become a subscriber? Go to our PRICING page.

Select New Cannabinoid

Filter Cannabinoid

Members can filter by the following criteria:

  • Study Type
  • Organ Systems
  • Terpenes
  • Receptors
  • Ligands
  • Study Result
  • Year of Publication

Overview - Pentadecanoylcarnitine (PDC)

Description of Pentadecanoylcarnitine (PDC)

Pentadecanoylcarnitine (PDC) is a novel endocannabinoid (discovered 2022) that is associated with activities relevant to both physical and mental health. PDC is an endogenous metabolite derived from the dietary odd-chain fatty acid pentadecanoic acid (C15:0).

C15:0 occurs naturally (but only in relatively small amounts) in whole fat milk and butter, lard, beef, sheep, fish and fish derived oils; in some vegetables (e.g., cucumber cabbage); and in algae and seaweed.

Large cohort trials have shown that higher dietary intake of C15:0 are associated with a lower overall mortality and increased longevity.

C15:0 is available as a dietary supplement and a pre-clinical trial found that is was able to lower glucose, cholesterol, pro-inflammatory cytokines, as well as body weight in a mouse model of obesity and type 2 diabetes.

Other Names:


C15 carnitine, pentadecanoylcarnitine, O-pentadecanoylcarnitine

IUPAC Name: 3-pentadecanoyloxy-4-(trimethylazaniumyl)butanoate

Molecular Formula: C22H43NO4


Pentadecanoylcarnitine (PDC) Properties and Effects

Only Members can view Properties and Effects information. See DEMO page.

Pentadecanoylcarnitine (PDC) Receptor Binding

Only Members can view Receptor Binding information. See DEMO page.

Information on this site is provided for informational purposes only and is not meant to substitute for the advice provided by your own licensed physician or other medical professional. You should not use the information contained herein for diagnosing or treating a health problem or disease. If using a product, you should read carefully all product packaging. If you have or suspect that you have a medical problem, promptly contact your health care provider.

Information on this site is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over-the-counter medication is also available. Consult your physician, nutritionally oriented health care practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications.